Cognitive Function in Elderly Marathon Runners
APSOEM
Austrian Prospective Cohort Study in Cognitive Function of Elderly Marathon-runners
1 other identifier
observational
114
0 countries
N/A
Brief Summary
There is substantial research on the effects of physical exercise on cognitive functions. However, less attention has been paid on the requirements of training intensity and length to enhance cognitive abilities in the elderly. To the investigators knowledge no studies have evaluated the effects of extensive endurance exercise training on cognitive functions by studying elderly marathon runners and bicyclists. On the basis of the scientific literature published so far it is not known whether the beneficial impact of endurance exercise training depends on the intensity of training. The investigators therefore designed a cohort study with adequate power in order to evaluate the effects of intensive endurance exercise training on cognition. This trial, an Austrian prospective cohort study in cognitive function of elderly marathon-runners (APSOEM) is being conducted and will compare neuropsychological performance outcomes of elderly marathon runners or bicyclists with controls matched concerning age, education years, occupation, and verbal intelligence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2008
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 7, 2010
CompletedFirst Posted
Study publicly available on registry
January 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedResults Posted
Study results publicly available
July 11, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJune 26, 2018
March 1, 2018
5.2 years
January 7, 2010
March 15, 2016
March 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
the Proportion of Subjects, Who Will Develop Mild Cognitive Impairment
Hypothesis will be tested at the second follow-up examinations.
10 years
Brain-derived Neurotrophic Factor (BDNF)
Baseline and 5 years
Secondary Outcomes (2)
Self Rating by Questionnaires
Baseline and 5 years
Insulin-like Growth Factor (IGF-1)
Baseline and 5 years
Study Arms (2)
Controls
Controls were subsequently contacted via personal contact and three additional advertisements (two in an Austrian newspaper ("Krone") and one in an Austrian bicyclist journal ("Bicyclist Sports"). The controls were matched according to age, sex and years of education
marathon athletes
Runners participating in the 2008 Wachau half marathon (21,2 km) and the Vienna City marathon (42,5 km) as well as bicyclists participating at the Corinthian marathon (180km). Inclusion criteria:1) participation in at least one of these 3 marathons in the preceding two years,2)still in continuous training during the recruitment phase (at least 2 hours/week), 3) aged over 60. Exclusion criteria:(a) present or past exposure to neurotoxic substances (b) if they did not speak German as their native language (c) diseases that markedly affect CNS functions (d) manifest cardiovascular disease, (e) chronic alcoholism (daily alcohol intake \> 60 g or diagnosed history of alcoholism) and (f) unwillingness to give informed consent.
Eligibility Criteria
Marathon runners, bicyclists and controls from the greater Vienna area
You may qualify if:
- Current Marathon runners or marathon bicyclists and controls from the greater Vienna area
You may not qualify if:
- Current of past neurotoxic exposure
- Not German as native language
- Diseases, that might affect central nervous system (stroke, meningitis, meningeoma, hydrocephalus,..)
- Manifest cardiovascular disease
- Alcoholism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Viennalead
- National Bank of Austriacollaborator
Related Publications (2)
Mucher P, Batmyagmar D, Perkmann T, Repl M, Radakovics A, Ponocny-Seliger E, Lukas I, Fritzer-Szekeres M, Lehrner J, Knogler T, Tscholakoff D, Fondi M, Wagner OF, Winker R, Haslacher H. Basal myokine levels are associated with quality of life and depressed mood in older adults. Psychophysiology. 2021 May;58(5):e13799. doi: 10.1111/psyp.13799. Epub 2021 Mar 2.
PMID: 33655551DERIVEDWinker R, Lukas I, Perkmann T, Haslacher H, Ponocny E, Lehrner J, Tscholakoff D, Dal-Bianco P. Cognitive function in elderly marathon runners: cross-sectional data from the marathon trial (APSOEM). Wien Klin Wochenschr. 2010 Dec;122(23-24):704-16. doi: 10.1007/s00508-010-1485-z. Epub 2010 Nov 15.
PMID: 21072603DERIVED
Biospecimen
Apolipoprotein E4 genotype, Insulin-like growth factor-1, Brain-derived neurotrophic factor, rs6265-Genotype
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Robert Winker
- Organization
- Health and Prevention Center, Sanatorium Hera, Vienna, Austria
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass. Prof.
Study Record Dates
First Submitted
January 7, 2010
First Posted
January 8, 2010
Study Start
December 1, 2008
Primary Completion
February 1, 2014
Study Completion
December 1, 2018
Last Updated
June 26, 2018
Results First Posted
July 11, 2016
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share